绿叶制药(02186.HK) 公布,发行5,000万美元5.85%利率2025年到期可转换债券之所有先决条件已获达成,且发行相关债券已顺利完成。预期相关债券于新交所上市将于今日(16日)生效。
绿叶制药表示,是次发行可以改善集团的资金流动性以及替换部分短期贷款,是次发行债券所得款项净额将减少集团的资金成本并改善债务到期情况。(js/w)
(港股报价延迟最少十五分钟。沽空资料截至 2024-12-13 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.